A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

July 9, 2024

Study Completion Date

May 22, 2025

Conditions
Alzheimer Disease
Interventions
DRUG

LY3372689

given orally

DRUG

LY3372689

given orally

DRUG

Placebo

given orally

Trial Locations (69)

2010

St Vincent's Hospital, Sydney

2065

HammondCare Greenwich Hospital, Sydney

2077

Hornsby Ku-Ring-Gai Hospital, Sydney

2113

KARA Institute for Neurological Diseases, Sydney

2261

Central Coast Neurosciences Research (Tumbi Umbi), Central Coast

3053

NeuroCentrix, Carlton

3128

Box Hill Hospital, Box Hill

3144

HammondCare, Malvern

3146

Delmont Private Hospital, Glen Iris

4215

Private Practice - Dr PL Morris, Southport

5011

The Queen Elizabeth Hospital, Woodville

14203

University at Buffalo - UBMD Neurology, Buffalo

19001

Abington Neurological Associates, Ltd., Abington

19462

Keystone Clinical Studies, Plymouth Meeting

32162

Charter Research - Lady Lake, The Villages

32751

K2 Medical Research, Maitland

32940

ClinCloud - Viera, Melbourne

32952

Merritt Island Medical Research, LLC, Merritt Island

33026

VIN- Margarita Almeida El-Ramey, Pembroke Pines

33133

VIN-Andrew Lerman, Miami

33176

IMIC, Inc., Miami

VIN-Victor Faradji, Miami

33180

VIN-Julie Schwartzbard, Aventura

33428

Neurology Offices of South Florida, Boca Raton

33445

Brain Matters Research, Delray Beach

33462

JEM Research Institute, Atlantis

33912

Neuropsychiatric Research Center of Southwest Florida, Fort Myers

34470

Renstar Medical Research, Ocala

34652

Suncoast Clinical Research, Inc., New Port Richey

34997

Brain Matters Research, Stuart

46256

Josephson Wallack Munshower Neurology, PC, Indianapolis

75231

Kerwin Medical Center, Dallas

77054

The University of Texas Health Science Center at Houston, Houston

91303

Hope Clinical Research, Inc., Canoga Park

92123

Sharp Mesa Vista Hospital, San Diego

92614

Irvine Clinical Research, Irvine

93710

Neuro-Pain Medical Center, Fresno

4748511

National Center for Geriatrics and Gerontology, Ōbu

06510

Institute for Neurodegenerative Disorders, New Haven

02459

Boston Center for Memory, Newton

02360

Donald S. Marks M.D., P.C., Plymouth

02451

MedVadis Research Corporation, Waltham

02472

Adams Clinical, Watertown

07081

The Cognitive and Research Center of New Jersey, Springfield

08755

Advanced Memory Research Institute of New Jersey, Toms River

02914

Rhode Island Mood & Memory Research Institute, East Providence

05201-9810

The Memory Clinic, Bennington

K1N 5C8

Bruyère Research Institute, Ottawa

K1Z 1G3

Clinique de la Mémoire de l'Outaouais, Ottawa

Ottawa Memory Clinic, Ottawa

M3B 2S7

Toronto Memory Program, Toronto

J1L 0H8

Diex Recherche Sherbrooke Inc., Sherbrooke

672-8043

Himeji Central Hospital Affiliated Clinic, Himeji

650-0047

Kobe City Medical Center General Hospital, Kobe

302-0004

Memory Clinic Toride, Toride

879-5593

Oita University Hospital, Yufu

710-0813

Katayama Medical Clinic, Kurashiki

181-0013

Nozomi Memory Clinic, Mitaka-shi

179-0072

Kikukawa Clinic, Nerima City

113-0034

Memory Clinic Ochanomizu, Tokyo

61-853

Nzoz Neuro-Kard Ilkowski i Partnerzy SPL, Poznan

85-163

Centrum Medyczne NEUROMED, Bydgoszcz

31-559

Diamond Clinic, Krakow

53-203

Wroclawskie Centrum Alzheimerowskie, Wroclaw

01-684

Centrum Medyczne NeuroProtect, Warsaw

15-756

Podlaskie Centrum Psychogeriatrii, Bialystok

80-546

Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk

81-855

Centrum Medyczne SENIOR, Sopot

70-111

Centrum Medyczne Euromedis, Szczecin

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT05063539 - A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease | Biotech Hunter | Biotech Hunter